Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified August 2009 by Rapid Laboratories Inc..
Recruitment status was Recruiting

Sponsor:

Information provided by:

Rapid Laboratories Inc.

ClinicalTrials.gov Identifier:

NCT00951743

First received: July 31, 2009

Last updated: August 7, 2009

Last verified: August 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	July 2010
Estimated Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)